Skip to main content
Premium Trial:

Request an Annual Quote

He's Making a List, Checking it Twice

Speaking to National Cancer Institute leaders as well as both intramural and extramural investigators last Saturday, Harold Varmus began outlining his "provocative questions exercise," in which he aims to address unanswered questions in cancer research, reports Science Insider. According to Science, Varmus wishes to address "why testicular cancer can be cured with conventional chemotherapy and why obese people are more prone to certain cancers such as colon and breast cancer," and would like to "upend the conventional wisdom that it's impossible to find drugs that block so-called transcription factors, which are proteins that control the expression of genes." Science Insider says that one Varmus' list is complete, the NCI chief may "hold a special competition to invite proposals for several questions and fund, say, 15 of the best ideas."

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more